6-K

HOLDING(S) IN COMPANY

Company: Indivior Pharmaceuticals, Inc.
Filed: January 30, 2024
Period of Report: January 30, 2024
Accession Number: 0001654954-24-001051

View Document ↗ View on SEC.gov ↗